NIH-funded research NIH-funded research

Molecules in the brain that help short-term (working) memory

Official title: Chronic and acute molecular programs enabling working memory

Funded at Rockefeller University · NIH-11353911 · Data updated 2026-11-12

Researchers are exploring how a brain molecule called GPR12 helps short-term (working) memory, aiming to help people with ADHD and related memory problems.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRockefeller University
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 1, 2024
Project endApril 30, 2029
Funding year2026
Award (this year)$1,271,250
NIH project number4RF1MH133201-03
Project IDNIH-11353911 on NIH RePORTER

Who could benefit from this research

Could help

Although this is preclinical work that does not enroll people now, the findings would most directly apply to people with ADHD, schizophrenia, or other disorders causing working-memory problems and could make them candidates for future trials.

Less likely to help

People whose memory problems are due to non-neurological causes (such as medication side effects or sleep loss) or advanced neurodegenerative disease may be less likely to benefit from this molecular approach.

What this research studies

They will use animal models and advanced brain imaging to see how GPR12 affects communication between the thalamus and prefrontal cortex during working-memory tasks. The team will map steady-state gene activity and rapid, activity-dependent signaling tied to seconds-long memory processes using two-photon imaging, genetics, and molecular profiling. By linking molecular programs to specific patterns of neural activity during behavior, they hope to reveal mechanisms that keep short-term memory online. Results are intended to point to molecular targets that could be tested for therapies to improve working memory.

Why it matters

Potential benefit: Could identify new molecular targets for drugs or other therapies to improve working memory in ADHD, schizophrenia, and related conditions.

How similar studies have gone: Prior human and animal studies support roles for the prefrontal cortex and thalamus in working memory, but targeting the GPR12 molecular pathway is a novel and largely untested strategy.

Where this research is happening

  • Rockefeller University
    New York, United States
    Active

Researchers

  • Principal investigator: Rajasethupathy, Priya — Rockefeller University
  • Study coordinator: Rajasethupathy, Priya

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.